Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        GSK-4524101 by GSK for Solid Tumor: Likelihood of Approval
GSK-4524101 is under clinical development by GSK and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
                                                Data Insights
                                                
                                        GSK-4524101 by GSK for Breast Cancer: Likelihood of Approval
GSK-4524101 is under clinical development by GSK and currently in Phase II for Breast Cancer. According to GlobalData, Phase II...
